J. Verhelst

Details der Publikationsliste

Zeitraum

1997 - 2001

Anzahl

8

Co-Autoren

Endocrine consequences of long-term intrathecal administration of opioids (2000)

Abs, R ; JFA; CORA, Verhelst, J, Maeyaert, J, Van Buyten, JP, Opsomer, F, Adriaensen, Hugo; U0002245 ;, ...

Intrathecal administration of opioids is a very efficient tool in the long-term control of intractable nonmalignant pain. However, despite the well known role of opioids in endocrine regulation, few...

Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. (1999)

Verhelst, J, Abs, R, Maiter, D, Van Den Bruel, A, Vandeweghe, M, Velkeniers, B, ...

Cabergoline is a new long-acting dopamine agonist that is very effective and well tolerated in patients with pathological hyperprolactinemia. The aim of this study was to examine, in a very large...

Cabergoline in the treatment of acromegaly: a study in 64 patients. (1998)

Abs, R, Verhelst, J, Maiter, D, Van Acker, K, Nobels, F, Coolens, J L, ...

Cabergoline is a new, long acting, dopamine agonist that is more effective and better tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine agonists still have a place in...